Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Observational

Postural Training for Standing and Sitting in Men Suffering From Post-prostatectomy Urinary Incontinence

NCT06842914 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-03-01
Last updated
2025-02-24

Condition(s) studied

Men Who Have Undergone Prostatectomy

Investigational drug(s) / intervention(s)

postural training

postural training: postural training

Study summary

Existing research highlights the difficulty of identifying an optimal rehabilitation technique for improving male urinary continence. However, several authors have demonstrated the benefits of treatment based on improving movement control, often referred to as postural motor contro. The main principles are: respect for the neutral lumbopelvic position, reduction of intra-abdominal constraints and ecology of movement. With the aim of encouraging patient-centred clinical practice, patients are asked to fill in an assessment form on which they note the most disabling gestures with regard to their UI during the initial assessment. In our experience, 'sitting down or getting up from a chair' is the item most frequently and most severely reported. In practical terms, posture and body movements play a vital role in the management of pelvic strain. For example, excessive pressure on the bladder due to poor postural control would increase stress on the bladder. Optimal postural control would have the advantage of reducing and promoting continence mechanisms. If we take the example of the transition from sitting to standing, postural control aims to improve neuromuscular coordination and promote continence.

In the context of health education during the first session, it might be interesting to study the impact of modifying postural control when standing/sitting on urinary incontinence and how patients feel about it.

Eligibility

Sex
MALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Men over the age of majority. * Men who had had a prostatectomy within one year of inclusion. * Positive response to the question 'Do you leak urine when you stand or sit up? * Patients with a medical prescription for post-prostatectomy urinary incontinence rehabilitation. * Patients who are able to understand and follow the instructions relating to postural education when standing up or sitting down. * Patients who have read and understood the information note and who have not objected to participating in the research. * Patients affiliated to a social security scheme. Exclusion Criteria: * Urinary leakage before prostatectomy (diagnosed by a doctor) * Pad test ≤ 0 grams at the inclusion visit, before showing the postural control technique. * On anticholinergic treatment initiated less than 3 months ago. * Impossible to carry out postural control education (spinal surgery, serious neurological or orthopaedic pathology). * Patients deprived of their liberty by an administrative or judicial decision or protected adults (under guardianship or trusteeship). * Participation in other interventions: Individuals participating at the same time in other post-prostatectomy rehabilitation programmes or similar clinical studies.

Primary outcome measure(s)

  • the sign of the difference between the results of the two pad tests of 3 times 24 hours. — 15 days

Trial sites (2)

FacilityCityRegionStatus
Chu Rouen Rouen France
Ch bretagne atlantique Vannes France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06842914 on ClinicalTrials.gov ↗ ← All trials in France